Immunotherapy for chronic granulocytic leukaemia.
D000293:Adolescent; D000328:Adult; D001500:BCG Vaccine / Q000009:adverse effects; D002648:Child; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007951:Leukemia, Myeloid / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012075:Remission, Spontaneous
D001500:BCG Vaccine